GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » Cyclically Adjusted Price-to-FCF

Pediatrix Medical Group (Pediatrix Medical Group) Cyclically Adjusted Price-to-FCF : 2.46 (As of Apr. 27, 2024)


View and export this data going back to 1959. Start your Free Trial

What is Pediatrix Medical Group Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Pediatrix Medical Group's current share price is $9.04. Pediatrix Medical Group's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $3.68. Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF for today is 2.46.

The historical rank and industry rank for Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MD' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 2.31   Med: 11.24   Max: 31.7
Current: 2.46

During the past years, Pediatrix Medical Group's highest Cyclically Adjusted Price-to-FCF was 31.70. The lowest was 2.31. And the median was 11.24.

MD's Cyclically Adjusted Price-to-FCF is ranked better than
96.34% of 164 companies
in the Healthcare Providers & Services industry
Industry Median: 24.535 vs MD: 2.46

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pediatrix Medical Group's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.730. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $3.68 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pediatrix Medical Group Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group Cyclically Adjusted Price-to-FCF Chart

Pediatrix Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.09 6.30 6.95 3.78 2.53

Pediatrix Medical Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.78 3.83 3.66 3.35 2.53

Competitive Comparison of Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF

For the Medical Care Facilities subindustry, Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF falls into.



Pediatrix Medical Group Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=9.04/3.68
=2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pediatrix Medical Group's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Pediatrix Medical Group's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.73/129.4194*129.4194
=0.730

Current CPI (Dec. 2023) = 129.4194.

Pediatrix Medical Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.540 99.695 -0.701
201406 1.312 100.560 1.689
201409 1.555 100.428 2.004
201412 1.738 99.070 2.270
201503 -0.620 99.621 -0.805
201506 1.485 100.684 1.909
201509 1.761 100.392 2.270
201512 1.037 99.792 1.345
201603 -0.467 100.470 -0.602
201606 1.517 101.688 1.931
201609 2.006 101.861 2.549
201612 1.287 101.863 1.635
201703 -0.360 102.862 -0.453
201706 1.373 103.349 1.719
201709 2.044 104.136 2.540
201712 2.171 104.011 2.701
201803 -1.306 105.290 -1.605
201806 1.341 106.317 1.632
201809 1.469 106.507 1.785
201812 1.805 105.998 2.204
201903 -0.724 107.251 -0.874
201906 1.314 108.070 1.574
201909 1.934 108.329 2.311
201912 1.574 108.420 1.879
202003 -1.832 108.902 -2.177
202006 2.165 108.767 2.576
202009 1.968 109.815 2.319
202012 -0.225 109.897 -0.265
202103 -1.067 111.754 -1.236
202106 0.513 114.631 0.579
202109 0.587 115.734 0.656
202112 0.477 117.630 0.525
202203 -1.225 121.301 -1.307
202206 0.886 125.017 0.917
202209 0.923 125.227 0.954
202212 1.093 125.222 1.130
202303 -1.311 127.348 -1.332
202306 0.979 128.729 0.984
202309 0.853 129.860 0.850
202312 0.730 129.419 0.730

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pediatrix Medical Group  (NYSE:MD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Pediatrix Medical Group Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pediatrix Medical Group (Pediatrix Medical Group) Business Description

Traded in Other Exchanges
Address
1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. The company generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.
Executives
James D Swift officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Moore Mary Ann E officer: EVP Chief ERM/Legal Ops Off 1301 CONCORD TERRACE, SUNRISE FL 33323
Mark S Ordan director, officer: Chief Executive Officer 7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Shirley A Weis director 11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young director C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Lee Wood officer: EVP, Natl & Market Operations 1301 CONCORD TERRACE, SUNRISE FL 33323
Curtis Pickert officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky director 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel director, officer: PRES. & CHIEF EXEC. OFFICER 1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia officer: Principal Accounting Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson officer: Pres., PDX & OBX Medical Group C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards officer: EVP, Chief Financial Officer 7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Dominic J Andreano officer: Sr.VP,General Counsel & Secy. 1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos officer: EVP Chf Strategy & Growth Offi MEDNAX INC, 1301, SUNRISE FL 33323
Guy P Sansone director C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323